Key facts
- This page summarizes Denice Torres's Form 4 filing for 2seventy bio, Inc. (TSVT).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2024, 18:51.
Denice Torres - 10 Jun 2024 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)
- Reporting relationship
- Director
- Issuer ticker
- TSVT
- Reported as of
- 10 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 Jun 2024, 18:51:57 UTC
- Prior SEC filing
- 03 Jun 2024
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Iya Kessler, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Denice Torres filed Form 4 for 2seventy bio, Inc. (TSVT) on 12 Jun 2024.
Change
- Previous filing in this sequence was filed on 03 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TSVT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,050
- Change %
- +62%
- Price
- $0.000000
- Shares after
- 31,560
- Date
- 10 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TSVT
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- $0
- Shares
- +24,100
- Change %
- Price
- $0.000000
- Shares after
- 24,100
- Date
- 10 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,100
- Exercise price
- $3.93
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units vest 100% on the earlier of June 10, 2025 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
Footnote F2
This option vests 100% on the earlier of June 10, 2025 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
SEC remarks
Exhibit 24 Power of Attorney